• 1.

    Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3:1150.

    • Search Google Scholar
    • Export Citation
  • 2.

    Golden SH, et al.. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors: An Endocrine Society scientific statement. J Clin Endocrinol Metab 2012; 97:E1579E1639.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Yoon SS, Carroll MD, Fryar CD. Hypertension prevalence and control among adults: United States, 2011–2014. NCHS Data Brief 2015; 220:18.

    • Search Google Scholar
    • Export Citation
  • 4.

    Whelton PK, et al.. Research needs to improve hypertension treatment and control in African Americans. Hypertension 2016; 68:10661072.

  • 5.

    Genovese G, et al.. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329:841845.

  • 6.

    Friedman DJ, Pollak MR. Genetics of kidney failure and the evolving story of APOL1. J Clin Invest 2011; 121:33673374.

  • 7.

    Hansson L, et al.. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999; 353:611616.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8.

    Cleveland DR, et al.. Quality of prereferral care in patients with chronic renal insufficiency. Am J Kidney Dis 2002; 40:3036.

  • 9.

    Kinchen KS, et al.. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 2002; 137:479486.

  • 10.

    Boulware LE, et al.. Identification and referral of patients with progressive CKD: A national study. Am J Kidney Dis 2006; 48:192204.

  • 11.

    Junaid Nazar CM, et al.. Barriers to the successful practice of chronic kidney diseases at the primary health care level: A systematic review. J Renal Inj Prev 2014; 3:6167.

    • Search Google Scholar
    • Export Citation
  • 12.

    Thompson-Martin Y, McCullough PA, Agrawal V. Impact of an educational program for advanced practice nurses on Knowledge of Kidney Disease Outcomes Quality Initiative guidelines. Nephrol Nurs J 2015; 42:455460, quiz 496.

    • Search Google Scholar
    • Export Citation
  • 13.

    Mallappallil M. Distracted by dialysis: Effects on nephrology fellowship and careers. ASN Kidney News 2018; 10:1718.

  • 14.

    Nissenson AR, et al.. Opportunities for improving the care of patients with chronic renal insufficiency: Current practice patterns. J Am Soc Nephrol 2001; 12:17131720.

    • Search Google Scholar
    • Export Citation
  • 15.

    Ricardo AC, et al.. Influence of nephrologist care on management and outcomes in adults with chronic kidney disease. J Gen Intern Med 2016; 31:2229.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Murray MA, et al.. Whose choice is it? Shared decision making in nephrology care. Semin Dial 2013; 26:169174.

  • 17.

    Institute of Medicine. Unequal treatment: What healthcare providers need to know about racial and ethnic disparities in health care, March 2002. https://www.nap.edu/resource/10260/disparities_providers.pdf.

    • Search Google Scholar
    • Export Citation
  • 18.

    Ifudu O, et al.. Delayed referral of black, Hispanic, and older patients with chronic renal failure. Am J Kidney Dis 1999; 33:728733.

  • 19.

    Winkelmayer WC, et al.. Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis 2001; 38:11781184.

  • 20.

    Koraishy FM, et al.. Rate of renal function decline, race and referral to nephrology in a large cohort of primary care patients. Fam Pract 2017; 34:416422.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21.

    Coca SG, et al.. Plasma biomarkers and kidney function decline in early and established diabetic kidney disease. J Am Soc Nephrol 2017; 28:27862793.

  • 22.

    Nadkarni GN, et al.. Plasma biomarkers are associated with renal outcomes in individuals with APOL1 risk variants. Kidney Int 2018; 93:14091416.

Disparities in Identification of CKD

  • 1 Moro Salifu, MD, is professor and chair of the department of medicine, SUNY Downstate Medical Center in Brooklyn; Girish Nadkarni, MD, is assistant professor of medicine and Steven Coca, DO, MS, is associate professor of medicine, division of nephrology, Mount Sinai School of Medicine in New York; and Susanne B. Nicholas, MD, MPH, PhD, is associate professor of medicine in the divisions of nephrology and endocrinology, department of medicine, David Geffen School of Medicine at the University of California.
Restricted access
Save